Table 5.
Presence of bowel movements scored according to the Bristol Stool Chart (BSC) at 4 weeks in the 7 g RPS and placebo arms.
| Type 1 | Not Type 1 | p Value | |
|---|---|---|---|
| Placebo | 3 | 165 | 0.13 |
| 7 g RPS | 8 | 146 | |
| Type 1 or 2 | Not Type 1 or 2 | ||
| Placebo | 23 | 145 | 0.44 |
| 7 g RPS | 26 | 128 | |
| Type 7 | Not Type 7 | ||
| Placebo | 6 | 162 | 0.51 |
| 7 g RPS | 3 | 151 | |
| Type 6 or 7 | Not Type 6 or 7 | ||
| Placebo | 13 | 155 | 0.26 |
| 7 g RPS | 7 | 147 | |
| Type 5, 6 or 7 | Not Type 5, 6 or 7 | ||
| Placebo | 49 | 119 | 0.026 |
| 7 g RPS | 28 | 126 |
The last seven bowel movements recorded for each participant (corresponding with a 4-week timepoint) were scored according to the BSC and compared between the 7 g RPS and Placebo treatment groups using Fisher’s exact test.